Browse by author
Lookup NU author(s): Dr Paul Jowsey, Professor Peter Blain
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Sulphur mustard (SM) is a vesicating agent that has been used several times as a weapon during military conflict and continues to pose a threat as an agent of warfare/terrorism. After exposure, SM exerts both acute and delayed long-term toxic effects principally to the skin, eyes and respiratory system. These effects are thought to be mediated, at least in part, by direct interaction of SM with DNA, forming a myriad of DNA lesions and initiating effects on cell cycle and cell death pathways. Previous studies have demonstrated that a complex network of cellular DNA damage response pathways are utilised in cells exposed to SM, consistent with SM causing multiple forms of DNA damage. The present study focused on the role of Checkpoint kinase 1 (CHK1), a protein with putative roles in homologous recombination repair, p53 activation and the initiation of cell cycle checkpoints after certain forms of DNA damage. The data showed that SM caused robust activation of CHK1, monitored by multi-site phosphorylation analysis and that this activation was dependent on the ataxia telangiectasia and Rad3-related (ATR) protein kinase. Furthermore, specific inhibition of CHK1 increased SM toxicity in multiple human cell lines, with concomitant increases in markers of apoptosis, DNA damage and mitosis. Finally, the effect of CHK1 inhibition on SM toxicity was much more marked in cells with non-functional p53.
Author(s): Jowsey PA, Blain PG
Publication type: Article
Publication status: Published
Journal: Toxicology Letters
Year: 2015
Volume: 232
Issue: 2
Pages: 413-421
Print publication date: 22/01/2015
Online publication date: 18/11/2014
Acceptance date: 14/11/2014
ISSN (print): 0378-4274
ISSN (electronic): 1879-3169
Publisher: Elsevier Ireland Ltd.
URL: http://dx.doi.org/10.1016/j.toxlet.2014.11.013
DOI: 10.1016/j.toxlet.2014.11.013
PubMed id: 25448276
Altmetrics provided by Altmetric
